Search for: "BM"
Results 281 - 300
of 383
Sorted by Relevance
|
Sort by Date
25 Mar 2012, 4:08 pm
To date, the following providers have agreed to sponsor and appear as Table Vendors at the event (in alphabetical order): BMS Consultants, Inc.: www.bmsconsultants.com CED Investigative Technologies: http://www.ced-aai.com/ Courtside Documents: http://www.courtsidedoc.com/ Digital Justice: http://www.digitaljustice.net/ Exhibit A: http://www.exhibitadigital.com/ Minnesota Lawyers' Mutual: http://www.mlmins.com/ Northeastern Rehabilitation Associates: www.nerehab.com … [read post]
31 Aug 2015, 7:31 am
Additional Resources: UPDATED: J&J-Bayer and Pfizer-BMS look for marketing advantages in real-world Xarelto, Eliquis data, September 2, 2015, FiercePharma, by Carly Herald More Blog Entries: Risk for Internal Bleeding after Taking Pradaxa, August 22, 2014, Boston Dangerous Drugs Injury Lawyer Blog The post Xarelto and Eliquis Makers Fighting for Market Share Despite Safety Risks appeared first on Product Liability Lawyer Blog. [read post]
6 Jun 2012, 9:15 am
A good example of how these scores will effect a carrier company comes from Athens; BM&I trucking was shut down by the Federal Motor Carrier Safety Administration because they a score of 90 or more in three out of the five categories. [read post]
20 Aug 2010, 12:56 pm
Significant Case Studies Give You The Chance To Learn About New Partnerships and New Agreements In The Industry * BMS and Allergan * Merck and Schering-Plough * Sanofi-Aventis and Intelliject * J&J and Takeda * Eli Lilly and Kowa Pharmaceuticals * Eli Lilly and Incyte Corporation The Perfect Pitch: Biotech Investment Challenge In this groundbreaking session, Biotech companies will have the chance to present your new research and new therapies (either in early stages or mid-late stages)… [read post]
23 Feb 2009, 8:22 am
And as coconspirators, or aiders and abettors, they would be liable to everyone whom BM injured, not just to the people who invested in BM through their institutions. [read post]
27 Apr 2011, 2:29 pm
(Oct. 6, 2009), available at http://www.arl.org/bm~doc/gbs_groupprivacy.pdf. 2 Authors Guild v. [read post]
7 Apr 2011, 1:54 am
Three appeal court judges ruled that the order imposed on BM, a 38-year-old British national, was so flawed that it could not be allowed to stand. [read post]
2 Apr 2024, 4:50 am
BMS appealed on a number of grounds which essentially related to the following three questions: a) What is the correct approach to plausibility? [read post]
20 Mar 2023, 7:52 am
In 2009, a BMS employee wrote: [I]t looks like we are into stalling some more. [read post]
6 Nov 2023, 5:51 am
In the recent UK decision Astellas v Teva [2023] EWHC 2571 (Pat) Mr Justice Mellor in the High Court considered sufficiency, inventive step and infringement of Astellas' formulation patent for mirabegron. [read post]
2 Apr 2019, 11:43 am
For example, Nomination asserted two other BMS conditions (the third, above, succeeded). [read post]
30 Jul 2023, 5:08 am
As the CJEU held in BMS v. [read post]
19 Sep 2015, 6:39 am
The first such license Mason issued on Monday, for example, reads: "Issued this 9/14/2015, Pursuant to Federal Court Order No. 15-CY-44, DLB, Morehead, Kentucky by Brian Mason [signature initials "BM"], Notary Public. [read post]
19 Jan 2025, 12:30 am
Inhibrx's has licensed its CD47 antibody technology to Celgene (BMS). [read post]
6 Feb 2019, 6:12 am
Regulation of medicinal productsGuestKat Frantzeska Papadopoulou explored the issue of the regulation of orphan drugs in the context of the General Court decision on an action brought by Bristol-Myers Squibb Pharma (BMS) against the Commission and the European Medicines Agency (EMA) in the case T‑329/16: Orphan Drugs, a successful regulation after all? [read post]
16 Aug 2013, 7:48 pm
Similarly Ranbaxy, even after its acquisition by Diachii has continued to challenges patents own by BMS for Entacavir. [read post]
8 Apr 2016, 9:14 am
(“Merial”) and Bristol-Myers Squibb(“BMS”) (together, “appellees”). [read post]
6 Aug 2024, 12:05 pm
(T 966/18) (July 2021)Sufficiency of broad functional genus and first medical use claims in Europe (T 0424/21) (Oct 2022)Plausibility demystified - a review of EPO case law before G 2/21 (Feb 2023)UK divergence from the EPO on plausibility (Sandoz v BMS), Part 1: Is the "plausibility" test the same for both sufficiency and inventive step? [read post]
29 May 2015, 2:39 pm
" The lawsuit named Hoffman Law Group (formerly Residential Litigation Group), its operators, Michael Harper, Benn Willcox, and attorney Marc Hoffman, and its affiliated companies, Nationwide Management Solutions, Legal Intake Solutions, File Intake Solutions, and BM Marketing Group, all based in North Palm Beach, Fla. [read post]
25 Jan 2023, 2:00 pm
So the opinion is a little quick to jump to the belief that you've got to prove something more than knowledge; I'm not sure that's (entirely) right.But Justice Irion is right that if you've got one of the types of additional conduct, then there's personal jurisdiction, but that (as Ford Motor Company and BMS suggest) you've got to make the appropriate focus on which types of products you're talking about. [read post]
